Drug intelligence / Profile preview

blood substitute - human

Development stage
Preclinical
Lead developer
NanoSanguis
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

"blood substitute - human" is an early-stage (Discovery phase) investigational synthetic blood substitute being developed by NanoGroup and its subsidiary nanoSanguis, a Polish biotechnology company. It is a perfluorocarbon (PFC) nano-emulsion designed to temporarily replace red blood cell function by transporting oxygen and carbon dioxide throughout the body. The active ingredient consists of perfluorocarbon nanoparticles (often referred to as nanorespirocytes) that physically dissolve and carry respiratory gases in a manner analogous to hemoglobin in red blood cells. The drug is intended for use in emergency medicine settings where a temporary substitute for red blood cell function is needed (e.g., acute blood loss or trauma).

Other names
artificial bloodartificial blood substitutenanorespirocytesred blood cell substituterespirocytessynthetic blood substitute

Beyond the preview

Go deeper on blood substitute - human.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on blood substitute - human.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call